Desq Long
Sign in
SEC FORM 4
$0.00

Cue Biopharma, Inc. (CUE)

Acquisition (code M) of 13,647 shares at $0 per share.

Reporting Person Meluzio Michael Vincent · Officer Title VP, Prin. Accounting Officer · Transaction Code M

Traded Aug 13, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0002138368-26-000007 · filed 2026-08-17 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Cue Biopharma, Inc. (CUE)." Disclosed 2026-08-17. https://desqlong.com/cards/0002138368-26-000007-1 (retrieved 2026-09-26).